Yount Deborah Lee
Known title: Chief Human Resources OfficerCIK: 0001926195
Associated companies
Transaction History
| ATRC | ▲ Buy | Grant | 14,853 | $0 | 3/1/2025 | View on chart |
| ATRC | ▼ Sell | Tax Withholding | 11,961 | $463K | 3/1/2025 | View on chart |
| ATRC | ▲ Buy | Grant | 707 | $14K | 6/28/2024 | View on chart |
| ATRC | ▼ Sell | Tax Withholding | 2,651 | $60K | 6/1/2024 | View on chart |
| ATRC | ▲ Buy | Grant | 19,294 | $0 | 3/1/2024 | View on chart |
| ATRC | ▼ Sell | Tax Withholding | 2,056 | $0 | 3/1/2024 | View on chart |
| ATRC | ▲ Buy | Grant | 98 | $3K | 12/29/2023 | View on chart |
| ATRC | ▲ Buy | Grant | 450 | $17K | 6/30/2023 | View on chart |
| ATRC | ▼ Sell | Tax Withholding | 2,589 | $119K | 6/1/2023 | View on chart |
| ATRC | ▲ Buy | Grant | 12,239 | $0 | 3/1/2023 | View on chart |
| ATRC | ▲ Buy | Grant | 294 | $10K | 12/30/2022 | View on chart |
| ATRC | ▲ Buy | Grant | 16,900 | $0 | 6/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
BTIG raises AtriCure price target to $63
BTIG raised its price target on AtriCure to $63. The new target sits above the current analyst consensus of $54.89 and exceeds the stock’s recent 52‑week high of $61.70. This adjustment may influence market expectations as the company trades near its recent support level of $27.47.
BTIG raises AtriCure price target to $63. BTIG raised its price target on AtriCure to $63. The new target sits above the current analyst consensus of $54.89 and exceeds the stock’s recent 52‑week high of $61.70. This adjustment may influence market expectations as the company trades near its recent support level of $27.47.